Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079482
Status:
COMPLETED
Last Update Posted:
2016-07-21
First Post:
2004-03-08
Brief Title:
Study of CEP-701 Lestaurtinib in Patients With Acute Myeloid Leukemia AML
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc